These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8843173)

  • 41. Erythrocyte Na(+)-H+ exchanger and Na(+)-Li+ countertransport activity in primary aldosteronism.
    Delva P; Pastori C; Degan M; Montesi G; Bassi A; Lechi A
    Eur J Clin Invest; 1994 Dec; 24(12):794-8. PubMed ID: 7705372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ethnic differences in red blood cell sodium/lithium countertransport and metabolic correlates of hypertension: an international collaborative study.
    Ragone E; Strazzullo P; Siani A; Iacone R; Russo L; Sacchi A; Cipriano P; Mancini M; Zhao G; Yuan XY; Li DY; Gong L
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):935-41. PubMed ID: 9715785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Raised affinity for extracellular sodium of the sodium-lithium countertransporter is associated with a family history of hypertension and uraemia in patients with renal disease.
    Carr SJ; Moore D; Sikand K; Norman RI
    Clin Sci (Lond); 1997 May; 92(5):497-503. PubMed ID: 9176024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated erythrocyte sodium-lithium counter-transport in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Senda T; Serizawa N; Negishi K; Katayama S
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):37-44. PubMed ID: 8792100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The apolipoprotein E2 allele modulates activity and maximal velocity of the sodium-lithium countertransporter.
    Wierzbicki AS; Hardman TC; Cheung J; Lambert-Hammill M; Patel S; Morrish Z; Lumb PJ; Lant AF
    Am J Hypertens; 2002 Jul; 15(7 Pt 1):633-7. PubMed ID: 12118912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents.
    Walker JD; Tariq T; Viberti G
    BMJ; 1990 Sep; 301(6753):635-8. PubMed ID: 2224216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular sodium membrane transport and cardiovascular risk factors in non-insulin-dependent diabetes mellitus.
    Foyle WJ; Fernandez M; Denver E; Sampson MJ; Pinkney J; Yudkin JS
    Metabolism; 1996 Aug; 45(8):961-5. PubMed ID: 8769352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sulphydryl group control of sodium-lithium countertransport kinetics: a membrane protein control abnormality in essential hypertension.
    Thomas TH; Rutherford PA; West IC; Wilkinson R
    Eur J Clin Invest; 1995 Apr; 25(4):235-40. PubMed ID: 7601199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Erythrocyte sodium-lithium countertransport in diabetic children: 12 months development and relationship with familial hypertension].
    Guarena C; Boero R; Quarello F; Cerruti F; Rolando B; Sacchetti C; Rosati C; Iadarola G; Piccoli G
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1205-7. PubMed ID: 1482260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relation of sodium-lithium countertransport activity to markers of cardiovascular risk in normotensive subjects.
    Hardman TC; Dubrey SW; Soni S; Lant AF
    J Hum Hypertens; 1995 Jul; 9(7):589-96. PubMed ID: 7562890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythrocyte sodium-lithium countertransport activity is related to membrane fluidity in IDDM patients.
    Dowd A; Thomas TH; Taylor R; Wilkinson R
    Diabetologia; 1994 Apr; 37(4):394-400. PubMed ID: 8063041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects.
    Siebers RW; Maling TJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S59-61. PubMed ID: 1708027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport.
    Carr S; Mbanya JC; Thomas T; Keavey P; Taylor R; Alberti KG; Wilkinson R
    N Engl J Med; 1990 Feb; 322(8):500-5. PubMed ID: 2300121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of the temporal effect of alcohol on human erythrocyte sodium-lithium countertransport in relation to membrane cholesterol and phospholipids.
    Adebayo GI; Gaffney P; Feely J
    Alcohol; 1996; 13(6):597-602. PubMed ID: 8949955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased sodium-lithium countertransport activity in red cells of IgA nephropathy patients.
    Boero R; Degli Esposti E; Fabbri A; Guarena C; Forneris G; Quarello F; Fusaroli M; Piccoli G
    Kidney Int; 1991 Dec; 40(6):1118-22. PubMed ID: 1762312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal thiol group modulation of sodium-lithium countertransport and membrane fluidity is associated with a disturbed relationship between serum triacylglycerols and membrane function in type II diabetes.
    Senior PA; Thomas TH; Marshall SM
    Clin Sci (Lond); 2000 Jun; 98(6):673-80. PubMed ID: 10814604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erythrocyte sodium-lithium countertransport: another link between essential hypertension and diabetes.
    Canessa M
    Curr Opin Nephrol Hypertens; 1994 Sep; 3(5):511-7. PubMed ID: 7804749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sodium-lithium countertransport in microalbuminuric insulin-dependent diabetic patients.
    Jones SL; Trevisan R; Tariq T; Semplicini A; Mattock M; Walker JD; Nosadini R; Viberti G
    Hypertension; 1990 Jun; 15(6 Pt 1):570-5. PubMed ID: 2347619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. G-protein beta3-subunit gene variant, blood pressure and erythrocyte sodium/lithium countertransport in essential hypertension.
    Poch E; González-Núñez D; Compte M; De la Sierra A
    Br J Biomed Sci; 2002; 59(2):101-4. PubMed ID: 12113397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of plasma phytanic acid levels in Refsum's disease on the behaviour of the erythrocyte membrane sodium-lithium countertransporter.
    Wierzbicki AS; Hardman TC; Lumb P; Sankaralingam A; Morrish Z; Patel F; Sidey MC; Gibberd FB
    Eur J Clin Invest; 1998 Apr; 28(4):334-8. PubMed ID: 9615914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.